ArticleVaccines2023

Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer.

Norma Hernández-Pedro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.